Form D · Other
Providence Medical Technology, Inc.
Walnut Creek, CA · CIK 0001672926
Offering snapshot reported Dec 28, 2016 · SEC filing
- Reported sold
- $7M Offering amount: $8.16M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 14, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 28, 2016 | Initial | $6,999,998 | No comparison | 2 | SEC filing |
| Oct 17, 2016 | Amendment | $3,686,360 | $832,745vs Apr 26, 2016 | 25 | SEC filing |
| Apr 26, 2016 | Initial | $2,853,615 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-277153
Series F Preferred Stock Financing
Source: Form D, filed Dec 28, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Cash | Director |
| James Hens | Director |
| Bruce Mc Cormack | Director |
| Bruce Mc Cormack, Md | Director |
| Evan Ng | Executive |
| Jeffrey D. Smith | Director, Executive |
| Arthur Taylor | Director |
| Ronald M. Thomas | Director |
Issuer details
Industry: Other (See others in industry)
Address:
1331 N. California Blvd. Suite 320
Walnut Creek, CA, 94596
Walnut Creek, CA, 94596